Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P-3074 cutaneous spray for male pattern baldness
2015-002877-40Phase 3Completed
- Sponsor
- Polichem
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in androgenetic alopecia (AGA) comparing P-3074 cutaneous spray with Vehicle spray (2 arms). Primary endpoint: Target Area Hair Count (TAHC) at vertex at 24 weeks. Started Apr 2016; status: completed.
02
Drugs
AD-3031
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on 2015-002877-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002877-40.